<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01265628</url>
  </required_header>
  <id_info>
    <org_study_id>HSC GATE Strategie</org_study_id>
    <secondary_id>161/2009BO2</secondary_id>
    <nct_id>NCT01265628</nct_id>
  </id_info>
  <brief_title>Validation of the GATE Software</brief_title>
  <acronym>ValGATE</acronym>
  <official_title>Validation of the GATE Software for Static Visual Field Examinations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haag-Streit AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of the differential luminance sensitivity (DLS) values at each test point
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of visual field data and comparison of the differential luminance sensitivity (DLS) values at each test point by applying two perimetric software versions.</measure>
    <time_frame>up to 14 days</time_frame>
    <description>each participant were examined 2 times at two seperate sessions within 14 days.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Visual Field Defects</condition>
  <arm_group>
    <arm_group_label>Glaucoma</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinitis pigmentosa (RP)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Anterior Ischemic Optic Neuropathy (AION)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>perimetry</intervention_name>
    <description>automated static perimetry with adapted GATE strategy</description>
    <arm_group_label>Glaucoma</arm_group_label>
    <arm_group_label>Retinitis pigmentosa (RP)</arm_group_label>
    <arm_group_label>Anterior Ischemic Optic Neuropathy (AION)</arm_group_label>
    <other_name>Octopus 900</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        selected from the eye hospital's database
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  physical, intellectual and linguistic abilities, in order to understand the test
             requirements

          -  spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt

          -  distant visual acuity &gt; 10/20

          -  isocoria, pupil diameter &gt; 3 mm

        Exclusion Criteria:

          -  pregnancy, nursing

          -  diabetic retinopathy

          -  asthma

          -  HIV+ or AIDS

          -  history of epilepsy or significant psychiatric disease

          -  medications known to effect visual field sensitivity

          -  acute ocular infections (e.g. keratitis, conjunctivitis, uveitis)

          -  severe dry eyes

          -  miotic drugs

          -  amblyopia

          -  squint

          -  nystagmus

          -  albinism

          -  keratoconus

          -  intraocular surgery (except for uncomplicated cataract surgery) performed &lt; 3 month
             prior to screening

          -  history or presence of macular disease and / or macular edema

          -  relevant opacities of central refractive media (cornea, lens, vitreous body)

          -  ocular trauma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Schiefer, Prof.Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tuebingen, Centre for Ophthalmology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Ophthalmology, Institute for Ophthalmic Research</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2010</study_first_submitted>
  <study_first_submitted_qc>December 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2010</study_first_posted>
  <last_update_submitted>January 25, 2012</last_update_submitted>
  <last_update_submitted_qc>January 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Ulrich Schiefer</investigator_full_name>
    <investigator_title>Prof. Dr. med. Ulrich Schiefer</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

